As of 2025-02-19, the Relative Valuation of Corcept Therapeutics Inc (CORT) is 20.92 USD. This relative valuation is based on P/E multiples. With the latest stock price at 72.60 USD, the upside of Corcept Therapeutics Inc based on Relative Valuation is -71.2%.
The range of the Relative Valuation is 11.90 - 31.02 USD.
Range | Selected | |
Trailing P/E multiples | 14.3x - 22.9x | 17.8x |
Forward P/E multiples | 10.3x - 20.3x | 15.3x |
Fair Price | 11.90 - 31.02 | 20.92 |
Upside | -83.6% - -57.3% | -71.2% |
Date | P/E |
2025-02-14 | 53.73 |
2025-02-13 | 54.39 |
2025-02-12 | 51.83 |
2025-02-11 | 50.32 |
2025-02-10 | 49.90 |
2025-02-07 | 50.25 |
2025-02-06 | 50.27 |
2025-02-05 | 50.57 |
2025-02-04 | 49.44 |
2025-02-03 | 49.17 |
2025-01-31 | 49.44 |
2025-01-30 | 51.64 |
2025-01-29 | 45.46 |
2025-01-28 | 44.82 |
2025-01-27 | 44.55 |
2025-01-24 | 44.32 |
2025-01-23 | 46.02 |
2025-01-22 | 43.61 |
2025-01-21 | 45.15 |
2025-01-17 | 40.86 |
2025-01-16 | 40.22 |
2025-01-15 | 39.73 |
2025-01-14 | 38.17 |
2025-01-13 | 37.72 |
2025-01-10 | 36.83 |
2025-01-08 | 38.19 |
2025-01-07 | 37.87 |
2025-01-06 | 38.17 |
2025-01-03 | 37.57 |
2025-01-02 | 36.92 |
2024-12-31 | 37.23 |
2024-12-30 | 37.57 |
2024-12-27 | 38.77 |
2024-12-26 | 39.62 |
2024-12-24 | 38.54 |
2024-12-23 | 37.61 |
2024-12-20 | 37.98 |
2024-12-19 | 37.79 |
2024-12-18 | 38.73 |
2024-12-17 | 40.74 |
2024-12-16 | 40.95 |
2024-12-13 | 40.93 |
2024-12-12 | 41.61 |
2024-12-11 | 44.39 |
2024-12-10 | 43.45 |
2024-12-09 | 43.78 |
2024-12-06 | 44.91 |
2024-12-05 | 43.90 |
2024-12-04 | 44.96 |
2024-12-03 | 44.09 |